Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.

In autoimmune disease, the immune system produces antibodies that target the body's own molecules and tissues.

When female mice are injected with a specific peptide from the ZP3 protein, their immune systems produce antibodies that target the native ZP3 protein, indicating that B cells in these mice do not recognize ZP3 as self and may be routinely activated by it.

Removing ovarian antigens before the immune system detects them does not stop the production of certain autoantibodies, suggesting that similar antigens present outside the ovaries can trigger this response.

In female mice, higher levels of antibodies targeting the ZP3 protein are linked to lower rates of fertility.

After immunization, antibodies targeting the ZP3 protein appear by day 7, before antibodies against a related T cell peptide are detected, showing that the immune system generates a specific type of fast-acting antibody response.

Certain immune system responses to non-ovarian peptides that resemble ZP3 can lead to the production of antibodies against ZP3, which may contribute to autoimmune reactions.